Cargando…
Identification of Circulating miR-762 as a Novel Diagnostic and Prognostic Biomarker for Non-Small Cell Lung Cancer
BACKGROUND: MicroRNAs (miRNAs) have been demonstrated to play critical roles in tumorigenesis of non-small cell lung cancer (NSCLC), and circulating miRNAs are a valuable source of biomarkers for the clinical management of NSCLC. The aim of this study was to determine the value of serum miR-762 as a...
Autores principales: | Chen, Lei, Li, Yunxia, Lu, Jingshu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7745551/ https://www.ncbi.nlm.nih.gov/pubmed/33317398 http://dx.doi.org/10.1177/1533033820964222 |
Ejemplares similares
-
miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
por: Ge, Peng, et al.
Publicado: (2019) -
miR-762 can negatively regulate menin in ovarian cancer
por: Hou, Rui, et al.
Publicado: (2017) -
Mitochondrial miR-762 regulates apoptosis and myocardial infarction by impairing ND2
por: Yan, Kaowen, et al.
Publicado: (2019) -
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
por: Valladares-Ayerbes, Manuel, et al.
Publicado: (2012) -
Identification of miR-124a as a novel diagnostic and prognostic biomarker in non-small cell lung cancer for chemotherapy
por: Luo, Pei, et al.
Publicado: (2017)